Low dose meloxicam is safe and tolerable when combined with toceranib phosphate in cancer-bearing cats.

Published in: Journal of feline medicine and surgery (2021)

Low dose meloxicam combined with toceranib is safe and well tolerated in cancer-bearing cats. Continued patient recruitment and data collection are needed to determine the maximum tolerated dose of meloxicam. The results of our study will guide further phase II/III trials.

Keyphrases

low dose
phase ii
papillary thyroid
clinical trial
squamous cell
high dose
open label
case report
randomized controlled trial
electronic health record
childhood cancer
machine learning
artificial intelligence